Ⅰ和Ⅱ级滤泡淋巴瘤单纯放疗的随访研究

导出

摘要 Ⅰ和Ⅱ级滤泡淋巴瘤（follicular lymphoma,FL）在所有非霍奇金淋巴瘤中分别占9.5％和6.2％,占所有FL的70％[1].目前FL分级采用世界卫生组织（WHO）分级标准,通过每高倍镜视野中的中心母细胞数量来确定[2].对于局限期FL,建议采用单纯放疗,但是放疗能否使局部控制率提高仍不明确[34].近年来有研究表明放疗可明显提高FL的总生存（OS）[5].目前利妥昔单抗单药或者联合化疗均可延长无进展生存期（PFS）[6],但是对于早期FL仍不明确.

作者栾宏辉纪少春李生兰牛广宇彭佳明

机构地区黑龙江省佳木斯中心医院放疗科

出处《国际肿瘤学杂志》 CAS 2015年第1期79-80,共2页 Journal of International Oncology

关键词非霍奇金淋巴瘤单纯放疗随访研究滤泡 LYMPHOMA 世界卫生组织无进展生存期利妥昔单抗

分类号 R733.1 [医药卫生—肿瘤]

引文网络
相关文献

参考文献15

1International Lymphoma Study Group.A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma.The non-Hodgkin's lymphoma classification project[J].Blood,1997,89 (11):3909-3918.
2Campo E,Swerdlow SH,Harris NL,et al.The 2008 WHO classification of lymphoid neoplasms and beyond:evolving concepts and practical applications[J].Blood,2011,117(19):5019-5032.
3Dreyling M,ESMO Guidelines Working Group.Newly diagnosed and relapsed follicular lymphoma:ESMO clinical recommendations for diagnosis,treatment and follow-up[J].Ann Oncol,2009,20 Suppl 4:119-120.
4Heinzelmann F,Engelhard M,Ottinger H,et al.Nodal follicular lymphoma:the role of radiotherapy for stages Ⅰ and Ⅱ[J].Strahlenther Onkol,2010,186(4):191-196.
5Pugh TJ,Ballonoff A,Newman F,et al.Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation:a surveillance,epidemiology,and end results database analysis[J].Cancer,2010,116(16):3843-3851.
6Dreyling M,Ghielmini M,Marcus R,et al.Newly diagnosed and relapsed follicular lymphoma:ESMO clinical practice guidelines for diagnosis,treatment and follow-up[J].Ann Oncol,2014,25 Suppl 3:76-82.
7Dancey JE,Dodd LE,Ford R,et al.Recommendations for the assessment of progression in randomised cancer treatment trials[J].Eur J Cancer,2009,45(2):281-289.
8Saad ED,Katz A.Progression-free survival and time to progression as primary end points in advanced breast cancer:often used,sometimes loosely defined[J].Ann Oncol,2009,20 (3):460-464.
9Eich HT,Heimann M,Stutzer H,et al.Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapy[J].Strahlenther Onkol,2009,185(5):288-295.
10Tsang RW,Gospodarowicz MK.Low-grade non-hodgkin lymphomas[J].Semin Radiat Oncol,2007,17(3):198-205.

1毕锡文,陈廷超,姜文奇.利妥昔单抗在淋巴瘤维持治疗中的新进展[J].中国肿瘤临床,2014,41(24):1612-1615. 被引量：9
2李晔雄.滤泡淋巴瘤[J].癌症进展,2004,2(3):166-173. 被引量：2
3于迎迎,李晓霞.PET／CT 在滤泡淋巴瘤中的研究进展[J].实用肿瘤学杂志,2015,29(2):140-143.
4吕铮.淋巴瘤诊断金标准[J].抗癌之窗,2010(5):22-22.
5黄洪晖.晚期滤泡性淋巴瘤的个体化治疗策略[J].内科理论与实践,2011,6(1):22-29. 被引量：3
6王蓉,范磊,王莉,吴雨洁,徐卫,李建勇.白血病期滤泡淋巴瘤1例并文献复习[J].临床血液学杂志,2014,27(5):806-808.
7尹浩,游潮,毛庆,蔡博文,丁昊,李强.中枢神经系统恶性黑色素瘤的诊断与治疗[J].中国修复重建外科杂志,2008,22(10):1209-1212. 被引量：5
8余细球,程芳洲,沈立云.三种肿瘤标志物在胃癌诊断中的应用[J].中国医师杂志,2001,3(12):935-936.
9马力文,贾廷珍.直肠癌的辅助治疗[J].中国肿瘤,2003,12(9):526-529.
10许家莹,任青玲,陆葳,郭红玉.阴道镜检查对303例宫颈疾病的诊断价值[J].重庆医学,2012,41(14):1415-1416. 被引量：6

国际肿瘤学杂志

2015年第1期

浏览历史

内容加载中请稍等...

Ⅰ和Ⅱ级滤泡淋巴瘤单纯放疗的随访研究

参考文献15

相关作者

相关机构

相关主题

浏览历史